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Introduction: Chronic wounds remain as a significant burden for patients and healthcare system. 
An important component in the pathogenesis of non-healing wounds is dysfunction of 
macrophages. In normal-healing wounds, the classically activated pro-inflammatory “M1” 
macrophages present at the early phases are replaced over time by alternatively activated “M2” 
macrophages, which stimulate angiogenesis and extracellular matrix deposition. However, most 
types of chronic wounds are characterized by persistence of the M1 phenotype. Strategies based 
on the use of mesenchymal stem cells (MSCs) have recently gained significant interest for the 
treatment of chronic wounds. In particular, accumulating experimental evidence suggests that 
MSCs favor the transition of M1 to M2 macrophages. These effects seem mostly mediated by 
paracrine factors secreted by the MSCs, including soluble factors and extracellular vesicles. 
However, the immunomodulatory role of the different components of the MSC secretome in the 
M1 to M2 transition remains largely unknown. 
Aim: The aim of this study was to assess the effects of the different components comprising the 
MSCs secretome on M1 macrophages in vitro 
Materials and methods: Cultured human adipose-derived stem cells (ASCs) were incubated in 
medium depleted of extracellular vesicles. The medium was harvested after 24 h and designated 
as the whole supernatant (WS). The WS was further divided into a soluble fraction (SF) and an 
extracellular vesicle (EV) fraction. The size and distribution of particles contained in the different 
fractions was determined by nanoparticle tracking analysis (NTA). M1 macrophages were 
obtained from the THP-1 human monocytic cell line after incubation in a pro-inflammatory cocktail. 
The M1 polarized cells were conditioned in the WS, SF or EV fraction for 48 h. The conditioned 
cells were labeled using antibodies against the CCR7 and CD163 receptors (as markers for M1 
and M2 subtypes) and assessed by fluorescence microscopy. Additionally, qRT-PCR was used 
to assess the transcriptional activity of CCR7 and CD163 genes. 
Results: While particles in the range of 40-180 nm (corresponding to exosomes and 
microvesicles) were found in the WS and EV fractions, no particles were detected in the SF 
fraction. Treatment with all three fractions attenuated the M1 phenotype, as evidenced by a 
decreased number of CCR7 and an increased number of CD163 positive cells. qRT-PCR analysis 
also revealed an anti-inflammatory effect from all three fractions, as evidenced by a significantly 
decreased transcription of CCR7 in the conditioned cells. However, only the WS and EV fractions 
significantly increased the transcriptional activity of CD163. These results suggest that the M1 to 
M2 transition appears to be mostly favored by components present in the EV fraction rather than 
in the SF counterpart. 
Conclusions: Our results indicate that EVs released by MSCs may play an important role as 
mediators of their pro-inflammatory properties. MSC-derived EVs may therefore represent a novel 
cell-free treatment for non-healing wound conditions. 
 
